Compare entities
Compare entities amongst all available in our database
Only available for companies for now
Gilead Sciences | Nextmind | |||
---|---|---|---|---|
Logo | ||||
Sector | Healthcare | Healthcare | ||
Industry | Biotechnology | Biotechnology | ||
Country (HQ) | United States | France | ||
CEO | Daniel P. O'Day (Male) | None (Male) | ||
Revenues ($) | 27,472,000,000 | 5,665,970 | ||
Employees | 14,400 | 20 | ||
Market Capitalization ($) | 80,337,200,000 | nan | ||
Profits ($) | 6,225,000,000 | nan | ||
Assets ($) | 67,952,000,000 | nan | ||
Revenue per employee | 1,907,778 | 283,298 | ||
Profits / Revenues (%) | 22.66 | |||
Market Cap / Revenues (x) | 2.92 | nan |